Back to search

Article

High daily dose Short COurse PrimaquinE after G6PD testing for the radical cure of<i>Plasmodium vivax</i>malaria in Indonesia and Papua New Guinea: The SCOPE implementation study protocol

2024-12-16

Abstract excerpt

<h4>Introduction</h4> Plasmodium vivax malaria remains an important threat to the public in the Asia Pacific region. Preventing P. vivax relapses is crucial for reducing morbidity from malaria and ultimately controlling and eliminating this species. Primaquine is the only widely available drug with antirelapse activity against dormant stages of P. vivax. Its widespread use in clinical practice is limited by its po...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c9b000da-63ea-5a4f-bd0d-f6c80dc3c02b
DOI
10.1101/2024.12.15.24318165
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
High daily dose Short COurse PrimaquinE after G6PD testing for the radical cure of<i>Plasmodium vivax</i>malaria in Indonesia and Papua New Guinea: The SCOPE implementation study protocolDOI 10.1101/2024.12.15.24318165
Select a neighboring publication to make it the new centre.